# Ketorolac Sublingual vs. Fentanyl Intranasal in Pain Control for Bilateral Myringotomy and Tubes (BMT) Placement in Children

> **NCT02653742** · PHASE4 · UNKNOWN · sponsor: **Anica Crnkovic** · enrollment: 150 (estimated)

## Conditions studied

- Pain, Postoperative
- Otitis Media

## Interventions

- **DRUG:** Ketorolac
- **DRUG:** Fentanyl

## Key facts

- **NCT ID:** NCT02653742
- **Lead sponsor:** Anica Crnkovic
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-05
- **Primary completion:** 2022-12
- **Final completion:** 2022-12
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2021-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02653742

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02653742, "Ketorolac Sublingual vs. Fentanyl Intranasal in Pain Control for Bilateral Myringotomy and Tubes (BMT) Placement in Children". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02653742. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*